ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 151 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $118,608,000 | -52.0% | 2,219,042 | +1.5% | 9.21% | -33.1% |
| Q4 2015 | $247,093,000 | -18.6% | 2,187,242 | -15.2% | 13.75% | -5.8% |
| Q3 2015 | $303,592,000 | +26.4% | 2,579,154 | -16.9% | 14.60% | +36.6% |
| Q2 2015 | $240,267,000 | +27.4% | 3,103,027 | -4.8% | 10.68% | +14.6% |
| Q1 2015 | $188,536,000 | +131.8% | 3,259,045 | +29.2% | 9.32% | +95.2% |
| Q4 2014 | $81,329,000 | +57.0% | 2,521,822 | +19.1% | 4.77% | +23.4% |
| Q3 2014 | $51,795,000 | +75.8% | 2,116,665 | +27.4% | 3.87% | +76.4% |
| Q2 2014 | $29,460,000 | -53.2% | 1,661,612 | -47.2% | 2.19% | -15.6% |
| Q1 2014 | $62,914,000 | +133.9% | 3,144,156 | +96.1% | 2.60% | +3.6% |
| Q4 2013 | $26,903,000 | +58.3% | 1,603,278 | +0.2% | 2.51% | +40.9% |
| Q3 2013 | $16,994,000 | +87.9% | 1,600,178 | -1.1% | 1.78% | +66.9% |
| Q2 2013 | $9,043,000 | – | 1,617,651 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |